Vivacelle Bio, Inc.
Publicly observedFort Wayne, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Fort Wayne | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Vivacelle Bio, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | DFXZMMZ9BB21 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant15 Sept 2026Publicly observed
NIH SBIR/STTR award: Development of a phospholipid nanoparticle and small molecule-based combination drug for the treatment of lethal sepsis
USD 690,878.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant15 Sept 2026Publicly observed
NIH SBIR/STTR award: Development of a Phospholipid Nanoparticle-based Volume Expander for Blood Volume Replacement and Organ Protection in Hemorrhagic Shock
USD 313,906.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.